QSP-UK AstraZeneca Macclesfield 2015

The meeting took place at AstraZeneca Macclesfield, from Monday 14th to Thursday 17th September 2015, as part of the Quantitative Systems Pharmacology Meetings series.


An abstract modelling framework for adverse outcome pathways
Understanding polypharmacology of antibodies: what are the benefits of using a bispecific vs combination of monospecifics?

Additional problems may be announced in due course.

Meeting Information and Registration

Further information about this meeting can be found on the meeting web page. Please address any queries to Dr Marcus Tindall.

Registration for this meeting has now closed.